Regulatory Approvals

Shanghai Bao Pharmaceuticals Co Announces U.S. FDA Approves Ind For Kj015 For Injection

By

Regulatory Approvals — Shanghai Bao Pharmaceuticals Co Announces U.S. FDA Approves Ind For Kj015 For Injection  TradingView

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. August 24, 2026.

By

Related Post

Regulatory Approvals

GC Biopharma wins approval for Hunter syndrome drug in India, Taiwan

Regulatory Approvals

Implantica’s anti-reflux device secures FDA approval to tee up J&J rivalry

Regulatory Approvals

FDA clears blood test to aid diagnostic test for Alzheimer’s Disease

Financial News For All

Labor

Morning Digest: Cleveland Public Library workers prepare to strike today

Labor

Cleveland Public Library union workers may strike

Regulatory Approvals

GC Biopharma wins approval for Hunter syndrome drug in India, Taiwan

Regulatory Approvals

Shanghai Bao Pharmaceuticals Co Announces U.S. FDA Approves Ind For Kj015 For Injection